Physician profile
Antonio J Ramirez
NPI 1063409076
$31,246.44
in general payments reported to CMS, 2019-2025
22 companies · $4,230 in 2025
The $4,230 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.44 · 2020: $47.77 · 2021: $7,177 · 2022: $680 · 2023: $5,919 · 2024: $13K · 2025: $4,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $19K · Honoraria: $2,250 · Food and Beverage: $1,670 · Long Term Medical Supply Or Device Loan: $245 · Travel and Lodging: $40.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $19,048.37 |
| Honoraria | $2,250.00 |
| Food and Beverage | $1,670.30 |
| Long Term Medical Supply Or Device Loan | $245.39 |
| Travel and Lodging | $40.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $27,069.33 | 2020-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $2,290.30 | 2023 | |
| Integra Lifesciences Corporation | $1,045.30 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Hologic Sales and Service, LLC | $159.07 | 2023-2024 | Coolseal Generator |
| Pacira Pharmaceuticals Incorporated | $83.50 | 2019-2025 | Exparel |
| Vertex Pharmaceuticals Incorporated | $71.45 | 2024-2025 | |
| Ethicon US, LLC | $67.94 | 2019-2025 | Echelon Endopath, Echelon Flex, Echelon; Endopath |
| Solventum Corporation | $64.28 | 2024-2025 | Activ.A.C., Prevena, V.A.C.Instill |
| Smith+Nephew, INC. | $49.25 | 2021 | |
| Allergan, INC. | $46.02 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.36 | 2022-2024 | Gattex |
| Aroa Biosurgery Incorporated | $41.69 | 2022-2023 | |
| Tela Bio, INC. | $32.86 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Conmed Corporation | $30.93 | 2024-2025 | Airseal |
| Guard Medical INC. | $30.00 | 2023 | Npseal Medium, Npseal (5), Npseal Large |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $24.85 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $23.05 | 2022 | |
| Organogenesis INC. | $18.84 | 2025 | Puraply Wound Matrix |
| Elucent Medical | $18.33 | 2023 | |
| Osiris Therapeutics INC. | $15.69 | 2019 | |
| Checkpoint Surgical, INC | $11.99 | 2019 | |
| Merit Medical Systems INC | $8.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.